Our mission is to help patients access life-saving therapies by transforming the drug development journey. Download the "Putting the patient first" report from our leadership roundtable: https://ow.ly/CCaH50SlZvv
Norstella’s Post
More Relevant Posts
-
Our first day at #Pharma2024! Samuel Ewing and I are connecting with drug developers and talking about how Doccla virtual hospital across Europe can enhance drug launches and make treatments more accessible and effective to people. Come and join the discussion! #digitalhealth #patientinsights #patientinnovation #marketaccess
We are here! Stop by booth 2 to explore how Europe's largest hospital can support your pharma programs. So far we've had augmented launches, patient support, treatment adherence and patient insights. We know there's more so if you also want to talk real world data, digital endpoints or market access then come and find me or Eduardo Arteaga Bracho at booth 2.
-
-
📈 As your clinical trials grow, so do regulatory, resource, and time pressures that can prevent you from scaling efficiently. Our webinar featuring Nicole Latimer and Roche Diagnostics' Khone Saysana and Walter S. dives into strategic eClinical solutions that can help you scale with ease. Watch it on-demand today: https://bit.ly/45NQJS2
-
-
Our Syneos Health Insights Hub! 👆 Click below to receive the latest biopharma insights directly to your inbox! 📬📩 📰 Subscribe to Syneos Health Weekly Sync https://ow.ly/VNfP30sGXiq #SyneosHealth #WorkHereMatterEverywhere #InsightsHub #BioParma #FutureFocussed #PatientTherapies #WeeklySync #WeeklyNewsletter
Want to receive the latest biopharma insights directly to your inbox? Subscribe to our newsletter, The Syneos Health Weekly Sync, today! https://ow.ly/VNfP30sGXiq #SyneosHealth
-
-
White Paper - Preparing for the At-Home Diagnostic Testing Revolution ixlayer At-home diagnostic testing is at the forefront of digital healthcare trends and has expanded exponentially across health issues. So, why should biopharma companies get involved in at-home testing and what are best practices to ensure success? Read Now: https://lnkd.in/dC9bQTvS
Build stronger connections with patients
go.ixlayer.com
-
Swift, adequate coverage 🌎 is vital to a biopharma product’s launch 🚀. Jeff Rothstein, Nancy Phelan and Kevin Patterson’s new study found the rebate strategy and unfavorable reimbursement and access lead to restrictions like utilization management. Increasingly, payers demand evidence beyond efficacy and safety. How do you solve for these? Check out their advice in this report - https://lnkd.in/dVYDw5kn #FutureReadyHealthcare
Achieving product launch success in the biopharma industry
indegene.com
-
How can we ensure essential treatments reach those in need in a world of growing payer restrictions? https://ow.ly/nS5q50SV0mW The Dedham Group, in collaboration with MMIT (Managed Markets Insight & Technology), surveyed 300+ pharma and biotech leaders to explore current and future patient access challenges. Discover the insights shaping the future of patient access with The State of Patient Access – Inaugural Report by clicking the link in this post.
-
-
In Parexel's latest edition of the New Medicines, Novel Insights newsletter, @Alex Gee, Senior Director, Parexel Access Consulting, shares the keys to establishing market access, why patient insights are essential, and how every drug developer can benefit from bringing access experts in by phase II. Learn how to demonstrate clinical and economic value, positioning your product for favorable coverage decisions that benefit the appropriate patient population. Like and subscribe to stay updated with more #NovelInsights! #MarketAccess #PatientEngagement #Reimbursement #HealthEconomics
To establish market access, start with unmet need: Why patient insights are central to reimbursement strategy
share.parexel.social
-
Vice President (Global leader) Integrated Solutions Strategy, DEI Leader, Co-Lead of Global Disability Steering Committee, Professor (hc), Entrepreneur in Residence, GlobalScot, Speaker and Board member.
In Parexel's latest edition of the New Medicines, Novel Insights newsletter, @Alex Gee, Senior Director, Parexel Access Consulting, shares the keys to establishing market access, why patient insights are essential, and how every drug developer can benefit from bringing access experts in by phase II. Learn how to demonstrate clinical and economic value, positioning your product for favorable coverage decisions that benefit the appropriate patient population. Like and subscribe to stay updated with more #NovelInsights! #MarketAccess #PatientEngagement #Reimbursement #HealthEconomics
To establish market access, start with unmet need: Why patient insights are central to reimbursement strategy
share.parexel.social
-
Meeting patients needs is the point of our industry - and in uncertain times making sure we are aligned to first principles is ever more important
In Parexel's latest edition of the New Medicines, Novel Insights newsletter, Alex Gee, Senior Director, Parexel Access Consulting, shares the keys to establishing market access, why patient insights are essential, and how every drug developer can benefit from bringing access experts in by phase II. Learn how to demonstrate clinical and economic value, positioning your product for favorable coverage decisions that benefit the appropriate patient population. Like and subscribe to stay updated with more #NovelInsights! #MarketAccess #PatientEngagement #Reimbursement #HealthEconomics
To establish market access, start with unmet need: Why patient insights are central to reimbursement strategy
share.parexel.social
Felix Perez, CEO Research Director
2moGreat to see your commitment to transforming the drug development journey and putting patients first! Looking forward to diving into the "Putting the Patient First" report and learning more about your innovative approaches. #PatientFirst #DrugDevelopment